Skip to content

Studying the Effects of Stellaria Media mother tincture on Rheumatoid Arthritis

To study the effectiveness of Stellaria media mother tincture in cases of Rheumatoid arthritis: An interventional uncontrolled clinical trial - nil

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/04/083969
Enrollment
34
Registered
2025-04-03
Start date
Unknown
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M059- Rheumatoid arthritis with rheumatoid factor, unspecified

Interventions

Intervention1: Stelleria media: Dose: 10-15 Drops of Mother tincture
Duration: As per the requirement of case
Total duration of intervention :As per the requirement of case Control Intervention1: NOT APPLICABLE: NOT APPLICABLE

Sponsors

Dr Dharmi Savaliya
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients aged 25- 70 years of age group will be screened, irrespective of gender. 2. Previously diagnosed Cases of rheumatoid arthritis or Cases diagnosed with ACR criteria of rheumatoid arthritis or Cases with the positive RA factor 3. The cases in which the totality of cases match with the symptom totality of Stellaria media. 4. Cases with functional change or with reversible pathology

Exclusion criteria

Exclusion criteria: 1. Cases presented with articular deformities or any other rheumatic complications. 2. The cases where totality of symptom of case does not match with symptom totality of Stellaria media. 3. Cases of pregnant ladies

Design outcomes

Primary

MeasureTime frame
VAS score (Visual Analogue Scale) Timepoint: At every follow up

Secondary

MeasureTime frame
Disease Activity Score 28 ESRTimepoint: At baseline & at end of treatment

Countries

India

Contacts

Public ContactDr.Dharmi Savaliya

Dr. V.H. Dave Homoeopathic Medical College and Smt. S.I. Patel (I) Homoeopathic Hospital

dr.sonal2705@yahoo.com9426432585

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Sep 19, 2026